Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cosmos HealthCOSM +0.78%29 Cash-to-Debt is 0.03 as of Mar. 2026, which is 63% below its 10-year median of 0.08. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.35 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Cosmos Health ranks worse than 95.76% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cosmos Health's cash to debt ratio for the quarter that ended in Mar. 2026 was 0.03.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Cosmos Healthcouldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Cosmos Health's Cash-to-Debt or its related term are showing as below:
COSM'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.08 Max: 1.73
Current: 0.03
During the past 13 years, Cosmos Health's highest Cash to Debt Ratio was 1.73. The lowest was 0.01. And the median was 0.08.
COSM's Cash-to-Debt is ranked worse than 95.76% of 118
companies
in the Medical Distribution industry
Industry Median: 0.625
vs COSM: 0.03
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Cosmos Health Cash-to-Debt Related Terms
Cosmos Health Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Cosmos Health's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Distribution subindustry, Cosmos Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health Cash-to-Debt vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (COSM) has a Cash-to-Debt of 0.03 as of Mar. 2026. This is 63% below median its historical median of 0.08. Over the past decade, Cosmos Health's Cash-to-Debt has ranged from 0.01 to 1.73. According to the industry distribution chart, Cosmos Health ranks #113 out of 118 companies in the Medical Distribution industry, placing it in the top 95.8%.
Is Cosmos Health's Cash-to-Debt too high?
Cosmos Health's current Cash-to-Debt of 0.03 is 63% below median its 10-year median of 0.08. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 1.73. The Medical Distribution industry median Cash-to-Debt is 0.63. Cosmos Health's value of 0.03 is 95.2% below this industry median. Based on the distribution chart, Cosmos Health ranks #113 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Cash-to-Debt compare to HKPD and MEDS?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #113 out of 118 companies for Cash-to-Debt. This places Cosmos Health in the lower half of its industry. The industry median Cash-to-Debt is 0.63. Cosmos Health's value of 0.03 is 95.2% below this benchmark. Historically, Cosmos Health's own Cash-to-Debt has ranged from 0.01 to 1.73 over the past decade. While the company's 10-year median is 0.08 vs. the industry median of 0.63, Cosmos Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Distribution company?
The median Cash-to-Debt among Medical Distribution companies is 0.63, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmos Health's current Cash-to-Debt of 0.03 is 95.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Cash-to-Debt is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Cash-to-Debt is 0.03, which is 63% below median its own 10-year median of 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.35, compared to a current price of $0.21 — trading 41.2% below its estimated fair value. The current Cash-to-Debt is 0.03, which is 63% below median its 10-year median of 0.08 and 95.2% below the Medical Distribution industry median of 0.63. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Cosmos Health (COSM), the current Cash-to-Debt is 0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.21 is trading 41.2% below its estimated GF Value™ of $0.35.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
Cash-to-Debt: 0.03 (63% below median its 10-year median of 0.08)
GF Value™: $0.35 vs. price of $0.21 (41.2% below fair value)
Industry Position: 95.2% below the Medical Distribution median (#113 of 118)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
